Pavan Vaddady
Overview
Explore the profile of Pavan Vaddady including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Vaddady P, Kandala B, Yee K
Antimicrob Agents Chemother
. 2020 Sep;
64(11).
PMID: 32868326
Doravirine is a non-nucleoside reverse transcriptase inhibitor for treatment of human immunodeficiency virus type 1 (HIV-1) infection. A population pharmacokinetic (PK) model for treatment-naive participants in doravirine clinical studies was...
12.
Greaves W, Wan H, Yee K, Kandala B, Vaddady P, Hwang C
Antimicrob Agents Chemother
. 2019 Sep;
63(12).
PMID: 31548188
Doravirine is a non-nucleoside reverse transcriptase inhibitor approved for the treatment of HIV-1. In a phase 1 trial, doravirine exposure was transiently decreased when treatment was started immediately after stopping...
13.
Feng H, Guo Z, Caro L, Marshall W, Liu F, Panebianco D, et al.
Clin Transl Sci
. 2018 Jul;
11(6):553-561.
PMID: 30040872
We conducted two phase I trials to evaluate the pharmacokinetic interactions between elbasvir (EBR), grazoprevir (GZR), and methadone (MK-8742-P010 and MK-5172-P030) in non-hepatitis C virus (HCV)-infected participants on methadone maintenance...
14.
Feng H, Guo Z, Caro L, Marshall W, Liu F, Panebianco D, et al.
Clin Transl Sci
. 2018 Jul;
11(6):562-572.
PMID: 30040871
The aims of these phase I trials were to evaluate the pharmacokinetic interaction between elbasvir (EBR) or grazoprevir (GZR) and buprenorphine/naloxone (BUP/NAL). Trial 1 was a single-dose trial in healthy...